$670 Million is the total value of SABBY MANAGEMENT, LLC's 132 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 94.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | BIOGEN INCcall | $95,146,000 | +97.1% | 3,354 | +85.9% | 14.20% | +46.6% | |
Sell | BIOGEN INCput | $66,920,000 | -1.7% | 2,359 | -7.3% | 9.99% | -26.9% | |
SELECT SECTOR SPDR TRput | $48,879,000 | +5.4% | 4,634 | 0.0% | 7.30% | -21.6% | ||
New | TESLA INCcall | $36,466,000 | – | 850 | +100.0% | 5.44% | – | |
Buy | ISHARES RUSSELL 2000put | $32,774,000 | +20.4% | 2,188 | +15.1% | 4.89% | -10.5% | |
Buy | SPDR S&P 500put | $31,178,000 | +65.8% | 931 | +52.6% | 4.65% | +23.3% | |
Buy | MODERNA INCput | $29,517,000 | +57.7% | 4,172 | +43.1% | 4.41% | +17.3% | |
Buy | SPDR S&P 500call | $29,035,000 | +67.8% | 867 | +54.5% | 4.34% | +24.9% | |
New | TESLA INCput | $21,402,000 | – | 435 | +100.0% | 3.20% | – | |
Buy | ASTRAZENECA PLCput | $16,851,000 | +372.0% | 3,075 | +355.6% | 2.52% | +250.9% | |
ISHARES RUSSELL 2000call | $15,728,000 | +4.6% | 1,050 | 0.0% | 2.35% | -22.2% | ||
Sell | SPDR SERIES TRUSTput | $14,898,000 | -42.5% | 1,337 | -42.2% | 2.22% | -57.2% | |
BIIB | Sell | BIOGEN INC | $12,634,000 | -54.6% | 44,536 | -57.1% | 1.89% | -66.2% |
Sell | ISHARES NASDAQ BIOTECHput | $12,498,000 | -13.2% | 923 | -12.3% | 1.87% | -35.4% | |
Buy | CEL-SCI CORPput | $9,911,000 | +115.4% | 7,773 | +152.0% | 1.48% | +60.2% | |
Buy | SELECT SECTOR SPDR TRcall | $8,797,000 | +32.0% | 834 | +25.2% | 1.31% | -1.9% | |
MRNA | Buy | MODERNA INC | $8,630,000 | +87.0% | 121,975 | +69.7% | 1.29% | +38.9% |
AZN | Buy | ASTRAZENECA PLCadr | $8,107,000 | +389.3% | 147,945 | +372.4% | 1.21% | +263.4% |
Sell | SORRENTO THERAPEUTICSput | $7,964,000 | +25.8% | 7,143 | -29.1% | 1.19% | -6.5% | |
Buy | MODERNA INCcall | $7,726,000 | +661.2% | 1,092 | +591.1% | 1.15% | +465.2% | |
Sell | BRAINSTORM CELL THERAPEUTICSput | $7,519,000 | -77.3% | 4,444 | -52.4% | 1.12% | -83.2% | |
SRNE | New | SORRENTO THERAPEUTICS | $6,760,000 | – | 606,298 | +100.0% | 1.01% | – |
New | PFIZER INCcall | $6,668,000 | – | 1,817 | +100.0% | 1.00% | – | |
Sell | PLURISTEM THERAPEUTICSput | $6,301,000 | +16.1% | 5,984 | -2.5% | 0.94% | -13.6% | |
Buy | CEL-SCI CORPcall | $5,871,000 | +100.9% | 4,605 | +135.1% | 0.88% | +49.2% | |
Buy | FIBROGEN INCput | $5,831,000 | +2.2% | 1,418 | +0.8% | 0.87% | -24.0% | |
New | CARDIFF ONCOLOGYput | $5,516,000 | – | 3,887 | +100.0% | 0.82% | – | |
New | BARCLAYS BANK PLCcall | $4,920,000 | – | 1,976 | +100.0% | 0.73% | – | |
IMMU | New | IMMUNOMEDICS INC | $4,252,000 | – | 50,000 | +100.0% | 0.64% | – |
ACAD | New | ACADIA PHARMACEUTICALS INC | $4,122,000 | – | 99,921 | +100.0% | 0.62% | – |
Sell | AVEO PHARMACEUTICALS INCput | $4,040,000 | +7.4% | 6,801 | -6.9% | 0.60% | -20.1% | |
RMTI | New | ROCKWELL MEDICAL INC | $3,847,000 | – | 3,595,415 | +100.0% | 0.57% | – |
New | SPI ENERGY CO LTD | $3,065,000 | – | 425,762 | +100.0% | 0.46% | – | |
ITCI | New | INTRA-CELLULAR THERAPIES | $2,951,000 | – | 115,000 | +100.0% | 0.44% | – |
New | ASTRAZENECA PLCcall | $2,855,000 | – | 521 | +100.0% | 0.43% | – | |
Buy | INOVIO PHARMACEUTICALSput | $2,814,000 | -51.7% | 2,426 | +12.3% | 0.42% | -64.0% | |
CIDM | New | CINEDIGM CORP | $2,755,000 | – | 4,875,949 | +100.0% | 0.41% | – |
Sell | TRILLIUM THERAPEUTICS INCcall | $2,643,000 | +43.6% | 1,860 | -18.2% | 0.40% | +7.0% | |
ISHARES NASDAQ BIOTECHcall | $2,559,000 | -0.9% | 189 | 0.0% | 0.38% | -26.3% | ||
CKPT | New | CHECKPOINT THERAPEUTICS | $2,496,000 | – | 931,240 | +100.0% | 0.37% | – |
VXX | New | BARCLAYS BANK PLCetf | $2,490,000 | – | 100,000 | +100.0% | 0.37% | – |
COCP | New | COCRYSTAL PHARMA INC | $2,480,000 | – | 2,667,293 | +100.0% | 0.37% | – |
SHIP | New | SEANERGY MARITIME | $2,443,000 | – | 5,349,284 | +100.0% | 0.36% | – |
XSPA | New | XPRESSPA GROUP INC | $2,347,000 | – | 1,191,233 | +100.0% | 0.35% | – |
NMRD | New | NEMAURA MEDICAL INC | $2,179,000 | – | 613,765 | +100.0% | 0.32% | – |
NVCN | Buy | NEOVASC INC | $2,160,000 | +178.4% | 1,009,406 | +209.6% | 0.32% | +106.4% |
PULM | Buy | PULMATRIX INC | $2,071,000 | +9761.9% | 1,740,663 | +14473.5% | 0.31% | +7625.0% |
Buy | CELLDEX THERAPEUTICcall | $2,064,000 | +102.9% | 1,392 | +78.0% | 0.31% | +51.0% | |
PRFX | New | PAINREFORM LTD | $2,047,000 | – | 444,941 | +100.0% | 0.31% | – |
Buy | IONIS PHARMACEUTICALScall | $2,031,000 | +177.8% | 428 | +245.2% | 0.30% | +106.1% | |
BLU | New | BELLUS HEALTH INC NEW | $1,999,000 | – | 880,400 | +100.0% | 0.30% | – |
DXR | New | DAXOR CORP | $1,928,000 | – | 122,406 | +100.0% | 0.29% | – |
EYEN | New | EYENOVIA INC | $1,899,000 | – | 608,720 | +100.0% | 0.28% | – |
CNTG | New | CENTOGENE N V | $1,724,000 | – | 182,275 | +100.0% | 0.26% | – |
IBB | Buy | ISHARES NASDAQ BIOTECHetf | $1,540,000 | +23.4% | 11,372 | +24.6% | 0.23% | -8.4% |
AFIB | New | ACUTUS MEDICAL INC | $1,480,000 | – | 49,656 | +100.0% | 0.22% | – |
INO | Buy | INOVIO PHARMACEUTICALS | $1,449,000 | +2583.3% | 124,884 | +6144.2% | 0.22% | +1863.6% |
CRIS | Sell | CURIS INC | $1,380,000 | -49.7% | 1,179,600 | -48.0% | 0.21% | -62.6% |
CVM | Buy | CEL-SCI CORP | $1,375,000 | +4.2% | 107,878 | +22.0% | 0.20% | -22.6% |
FGEN | Sell | FIBROGEN INC | $1,219,000 | -10.4% | 29,654 | -11.6% | 0.18% | -33.3% |
OLB | New | OLB GROUP INC | $1,166,000 | – | 311,010 | +100.0% | 0.17% | – |
SPCB | New | SUPERCOM LTD | $1,125,000 | – | 1,480,000 | +100.0% | 0.17% | – |
New | SAREPTA THERAPEUTICput | $1,067,000 | – | 76 | +100.0% | 0.16% | – | |
ODT | Buy | ODONATE THERAPEUTICS INC | $1,051,000 | -38.7% | 78,278 | +93.3% | 0.16% | -54.4% |
Buy | AURINIA PHARMACEUTICALScall | $1,037,000 | +128.9% | 704 | +152.3% | 0.16% | +70.3% | |
NRBO | Sell | NEUROBO PHARMACEUTICALS | $1,026,000 | -45.2% | 182,543 | -21.5% | 0.15% | -59.3% |
Sell | ALTIMMUNE INCput | $1,005,000 | -67.2% | 761 | -73.4% | 0.15% | -75.6% | |
Buy | IONIS PHARMACEUTICALSput | $1,006,000 | +1.5% | 212 | +26.2% | 0.15% | -24.6% | |
PDSB | New | PDS BIOTECHNOLOGY CORP | $978,000 | – | 419,836 | +100.0% | 0.15% | – |
Buy | SPDR GOLD TRUSTcall | $826,000 | -88.7% | 2,262 | +418.8% | 0.12% | -91.6% | |
TTNP | New | TITAN PHARMACEUTICALS | $803,000 | – | 4,856,723 | +100.0% | 0.12% | – |
RKDA | Buy | ARCADIA BIOSCIENCES INC | $770,000 | +243.8% | 275,123 | +362.1% | 0.12% | +155.6% |
GOVX | New | GEOVAX LABS INC | $768,000 | – | 240,654 | +100.0% | 0.12% | – |
GNCA | Buy | GENOCEA BIOSCIENCES INC | $716,000 | +148.6% | 312,666 | +149.5% | 0.11% | +84.5% |
New | EVOKE PHARMA INCput | $712,000 | – | 1,519 | +100.0% | 0.11% | – | |
New | AKERS BIOSCIENCES INC | $675,000 | – | 299,913 | +100.0% | 0.10% | – | |
BBI | New | BRICKELL BIOTECH INC | $652,000 | – | 721,887 | +100.0% | 0.10% | – |
New | AMARIN CORP PLCcall | $643,000 | – | 5,083 | +100.0% | 0.10% | – | |
EMBI | New | EMERALD BIOSCIENCE INC | $633,000 | – | 14,936,716 | +100.0% | 0.09% | – |
PSTI | Buy | PLURISTEM THERAPEUTICS | $629,000 | +139.2% | 59,730 | +101.1% | 0.09% | +77.4% |
LPCN | Buy | LIPOCINE INC NEW | $625,000 | +3372.2% | 443,469 | +2968.6% | 0.09% | +2225.0% |
New | SAREPTA THERAPEUTICcall | $618,000 | – | 44 | +100.0% | 0.09% | – | |
Buy | CATABASIS PHARMSput | $552,000 | +80.4% | 891 | +87.2% | 0.08% | +34.4% | |
Buy | POLARITYTE INCput | $501,000 | +1904.0% | 4,816 | +2308.0% | 0.08% | +1400.0% | |
Buy | XPRESSPA GROUP INCput | $497,000 | +252.5% | 2,522 | +648.4% | 0.07% | +164.3% | |
Sell | ODONATE THERAPEUTICS INCput | $475,000 | -76.4% | 354 | -25.5% | 0.07% | -82.4% | |
CYCC | New | CYCLACEL PHARMACEUTICALS | $458,000 | – | 125,578 | +100.0% | 0.07% | – |
New | CARDIFF ONCOLOGYcall | $450,000 | – | 317 | +100.0% | 0.07% | – | |
ADTX | New | ADITX THERAPEUTICS INC | $439,000 | – | 224,971 | +100.0% | 0.07% | – |
XLV | Sell | SELECT SECTOR SPDR TRetf | $422,000 | -96.0% | 4,000 | -96.2% | 0.06% | -97.0% |
PAVMZ | Sell | PAVMED INC*w | $364,000 | -58.0% | 436,973 | -48.1% | 0.05% | -69.0% |
CYTOKINETICS INCcall | $340,000 | -8.1% | 157 | 0.0% | 0.05% | -31.1% | ||
USEG | New | U S ENERGY CORP WY | $333,000 | – | 66,504 | +100.0% | 0.05% | – |
SCPH | Sell | SCPHARMACEUTICALS INC | $316,000 | -65.9% | 42,407 | -66.3% | 0.05% | -74.7% |
New | CALADRIUS BIOSCIENCESput | $293,000 | – | 1,630 | +100.0% | 0.04% | – | |
MKGI | New | MONAKER GROUP INC | $297,000 | – | 134,585 | +100.0% | 0.04% | – |
PHAS | Buy | PHASEBIO PHARMACEUTICALS | $279,000 | -21.2% | 79,470 | +3.2% | 0.04% | -40.8% |
Sell | GENOCEA BIOSCIENCES INCcall | $236,000 | -51.7% | 1,032 | -51.5% | 0.04% | -64.3% | |
SNCA | Buy | SENECA BIOPHARMA INC | $229,000 | +175.9% | 393,411 | +242.1% | 0.03% | +100.0% |
AUPH | Sell | AURINIA PHARMACEUTICALS | $200,000 | -50.7% | 13,544 | -45.8% | 0.03% | -63.0% |
New | HEPION PHARMACEUTICALSput | $184,000 | – | 591 | +100.0% | 0.03% | – | |
ALT | New | ALTIMMUNE INC | $182,000 | – | 13,800 | +100.0% | 0.03% | – |
HEPA | New | HEPION PHARMACEUTICALS | $178,000 | – | 57,309 | +100.0% | 0.03% | – |
CLBS | New | CALADRIUS BIOSCIENCES | $173,000 | – | 96,001 | +100.0% | 0.03% | – |
Buy | CATABASIS PHARMScall | $171,000 | +163.1% | 277 | +174.3% | 0.03% | +100.0% | |
GOVXW | New | GEOVAX LABS INC*w | $169,000 | – | 191,657 | +100.0% | 0.02% | – |
New | ACTINIUM PHARMACEUTICALSput | $159,000 | – | 164 | +100.0% | 0.02% | – | |
AVEO | Sell | AVEO PHARMACEUTICALS INC | $155,000 | -65.6% | 26,039 | -70.2% | 0.02% | -74.4% |
New | EMAGIN CORP NEWput | $149,000 | – | 1,172 | +100.0% | 0.02% | – | |
New | 9 METERS BIOPHARMAput | $145,000 | – | 1,773 | +100.0% | 0.02% | – | |
New | NABRIVA THERAPEUTICS PLC | $143,000 | – | 268,109 | +100.0% | 0.02% | – | |
New | CORDMEDIX INCcall | $142,000 | – | 236 | +100.0% | 0.02% | – | |
New | CURIS INCcall | $132,000 | – | 1,131 | +100.0% | 0.02% | – | |
New | LIPOCINE INC NEWcall | $133,000 | – | 941 | +100.0% | 0.02% | – | |
New | ADAMIS PHARMACEUTICALS CORPput | $122,000 | – | 1,565 | +100.0% | 0.02% | – | |
Sell | BAUDAX BIO INCput | $114,000 | -40.0% | 410 | -10.7% | 0.02% | -55.3% | |
EVOK | New | EVOKE PHARMA INC | $105,000 | – | 22,382 | +100.0% | 0.02% | – |
CTXR | New | CITIUS PHARMACEUTICALS | $92,000 | – | 88,711 | +100.0% | 0.01% | – |
BIOL | New | BIOLASE INC | $92,000 | – | 333,458 | +100.0% | 0.01% | – |
MDGSW | Sell | MEDIGUS LTD*w | $93,000 | -24.4% | 544,940 | -7.0% | 0.01% | -44.0% |
Buy | LM FUNDING AMERICA INC | $97,000 | +185.3% | 147,304 | +489.2% | 0.01% | +100.0% | |
ENERGY FOCUSput | $82,000 | -1.2% | 120 | 0.0% | 0.01% | -29.4% | ||
BNTC | BENITEC BIOPHARMA INC | $75,000 | -20.2% | 11,863 | 0.0% | 0.01% | -42.1% | |
NSPR | Buy | INSPIREMD INC | $77,000 | +250.0% | 243,900 | +405.0% | 0.01% | +175.0% |
New | CORDMEDIX INCput | $66,000 | – | 109 | +100.0% | 0.01% | – | |
New | NABRIVA THERAPEUTICS PLCput | $51,000 | – | 958 | +100.0% | 0.01% | – | |
New | ZOMEDICA PHARMACEUTICALS | $52,000 | – | 470,548 | +100.0% | 0.01% | – | |
BKYI | New | BIO KEY INTL INC | $44,000 | – | 100,000 | +100.0% | 0.01% | – |
CJJD | CHINA JO JO DRUGSTORES | $48,000 | -30.4% | 50,000 | 0.0% | 0.01% | -50.0% | |
TRANSENTERIX INCput | $28,000 | -34.9% | 794 | 0.0% | 0.00% | -55.6% | ||
Buy | PARETEUM CORPput | $20,000 | +66.7% | 299 | +57.4% | 0.00% | +50.0% | |
Buy | LIPOCINE INC NEWput | $21,000 | +61.5% | 150 | +50.0% | 0.00% | 0.0% | |
RWLK | Exit | REWALK ROBOTICS LTD | $0 | – | -19,082 | -100.0% | -0.01% | – |
TEUM | Exit | PARETEUM CORP | $0 | – | -56,757 | -100.0% | -0.01% | – |
Exit | CELSION CORPput | $0 | – | -145 | -100.0% | -0.01% | – | |
ENLV | Exit | ENLIVEX THERAPEUTICS LTD | $0 | – | -12,925 | -100.0% | -0.01% | – |
MARK | Exit | REMARK HOLDINGS INC | $0 | – | -33,953 | -100.0% | -0.02% | – |
Exit | REMARK HOLDINGS INCput | $0 | – | -413 | -100.0% | -0.02% | – | |
HOTH | Exit | HOTH THERAPEUTICS INC | $0 | – | -68,681 | -100.0% | -0.04% | – |
Exit | ALTIMMUNE INCcall | $0 | – | -189 | -100.0% | -0.04% | – | |
BPTH | Exit | BIO PATH HLDGS INC | $0 | – | -45,000 | -100.0% | -0.05% | – |
XBI | Exit | SPDR SERIES TRUSTetf | $0 | – | -2,150 | -100.0% | -0.05% | – |
Exit | CELSION CORPcall | $0 | – | -653 | -100.0% | -0.05% | – | |
AIKI | Exit | AIKIDO PHARMA INC | $0 | – | -342,121 | -100.0% | -0.06% | – |
Exit | ORAMED PHARMS INCput | $0 | – | -949 | -100.0% | -0.07% | – | |
ATNM | Exit | ACTINIUM PHARMACEUTICALS | $0 | – | -972,285 | -100.0% | -0.07% | – |
Exit | PREDICTIVE ONCOLOGY INC | $0 | – | -223,540 | -100.0% | -0.07% | – | |
GNPX | Exit | GENPREX INC | $0 | – | -118,584 | -100.0% | -0.08% | – |
Exit | TRILLIUM THERAPEUTICSput | $0 | – | -527 | -100.0% | -0.09% | – | |
YTRA | Exit | YATRA ONLINE INC | $0 | – | -650,000 | -100.0% | -0.09% | – |
IMUX | Exit | IMMUNIC INC | $0 | – | -53,009 | -100.0% | -0.13% | – |
AVGR | Exit | AVINGER INC | $0 | – | -2,183,464 | -100.0% | -0.14% | – |
MBIO | Exit | MUSTANG BIO INC | $0 | – | -234,778 | -100.0% | -0.15% | – |
SOLY | Exit | SOLITON INC | $0 | – | -102,891 | -100.0% | -0.16% | – |
Exit | ODONATE THERAPEUTICS INCcall | $0 | – | -223 | -100.0% | -0.19% | – | |
CLDX | Exit | CELLDEX THERAPEUTICS INC | $0 | – | -73,094 | -100.0% | -0.19% | – |
NKLAW | Exit | NIKOLA CORP*w | $0 | – | -34,500 | -100.0% | -0.23% | – |
GLBS | Exit | GLOBUS MARITIME LTD | $0 | – | -4,776,735 | -100.0% | -0.26% | – |
Exit | AVEO PHARMACEUTICALS INCcall | $0 | – | -4,255 | -100.0% | -0.44% | – | |
Exit | NIKOLA CORPput | $0 | – | -345 | -100.0% | -0.47% | – | |
ALNA | Exit | ALLENA PHARMACEUTICALS | $0 | – | -1,531,446 | -100.0% | -0.49% | – |
PLL | Exit | PIEDMONT LITHIUM LTD | $0 | – | -498,259 | -100.0% | -0.58% | – |
XERS | Exit | XERIS PHARMACEUTICALS | $0 | – | -1,086,031 | -100.0% | -0.58% | – |
Exit | SORRENTO THERAPEUTICS INCcall | $0 | – | -5,155 | -100.0% | -0.65% | – | |
Exit | SPDR GOLD TRUSTput | $0 | – | -215 | -100.0% | -0.72% | – | |
Exit | INOVIO PHARMACEUTICALScall | $0 | – | -2,494 | -100.0% | -1.35% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
ISHARES TR | 35 | Q3 2023 | 52.2% |
SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
BIOGEN INC | 24 | Q1 2021 | 26.2% |
SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
BIOGEN INC | 23 | Q1 2021 | 13.7% |
SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.